Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

Concentration Risk Continues: Why Now’s the Time to Diversify

BY | ETF Database
9:00 am ET 07/22/26 | 6 VIEWS
It’s hard to avoid the daily market headlines touting huge moves for AI firms, or the latest volatility from the Strait of Hormuz. However, events-based news often obfuscates the subtler stories that can really define a portfolio’s performance. This year, concentration risk is shaping up to be one of the defining stories — and there’s no time like the present to address it.Key Takeaways: Concentration risk is high, with the top 10 of the S&P 500 making up just under 40% of that index. QINT provides ex-U.S. quality stock exposure, which helps investors to diversify away from U.S. concentration risk. The ETF has outperformed its category average over the past year with a 22.7% gain, making it a compelling option. How significant is concentration risk right now? Recent analysis suggests that the top 10 holdings comprise just under 40% of the S&P 500 right now. That marks a notable increase from 26% in spring 2023. Should those top names begin to teeter, or worse, actively sell off, heavily concentrated portfolios would feel the impact acutely. Where, and how, then, should investors diversify? Rather than continue to add U.S. equities exposure, it may be worth considering international equities. The American Century Quality Diversified International ETF (QINT B+) holds a special place in that realm, combining international equities with a quality screen. Charging 34 basis points, QINT tracks the American Century Quality Diversified International Equity Index. In doing so, it targets large and midcap stocks outside the U.S. The index emphasizes a few important metrics like strong financials, growth prospects, and attractive fundamentals. Depending on market conditions, too, the quality international equities fund shifts between value and growth. So how has it performed? See more: American Century’s Testani on How to Beat Concentration Risk QINT has returned 22.7% over the past 12 months, according to ETF Database data. That return allowed the fund to outperform its ETF Database Foreign Large Cap Equities category average over the same period. What’s more, per YCharts data, the fund’s price is close to rising past its 50 and 200-day Simple Moving Averages (SMAs), a classic buy signal. Taken together, these factors combined make QINT an appealing option to balance portfolios against rising U.S. market concentration. For more news, information, and analysis, visit the Core Strategies Content Hub. VettaFi LLC (“VettaFi”) is the index provider for QINT, for which it receives an index licensing fee. However, QINT is not issued, sponsored, endorsed, or sold by VettaFi, and VettaFi has no obligation or liability in connection with the issuance, administration, marketing, or trading of QINT.

More Commentary

Riding the Multi-Year Nuclear Bull Market With URNM
BY | ETF Database
10:23 am ET 07/22/26 | 4 VIEWS
ETFs for the Next Leg of Earnings Expansion
BY | ETF Database
6:06 am ET 07/22/26 | 39 VIEWS
Bitcoin Rally May Have Legs; Bank Income With BTCI
BY | ETF Database
7:25 am ET 07/22/26 | 13 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.